相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
Francesco Maura et al.
LEUKEMIA (2020)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
The evolutionary history of 2,658 cancers
Moritz Gerstung et al.
NATURE (2020)
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al.
NATURE (2020)
Moving From Cancer Burden to Cancer Genomics for Smoldering Myeloma A Review
Francesco Maura et al.
JAMA ONCOLOGY (2020)
Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma
Bachisio Ziccheddu et al.
BLOOD ADVANCES (2020)
Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis
Verena Koerber et al.
CANCER CELL (2019)
Translating insights into tumor evolution to clinical practice: promises and challenges
Matthew W. Fittall et al.
GENOME MEDICINE (2019)
A Compendium of Mutational Signatures of Environmental Agents
Jill E. Kucab et al.
CELL (2019)
A practical guide for mutational signature analysis in hematological malignancies
Francesco Maura et al.
NATURE COMMUNICATIONS (2019)
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
Ola Landgren et al.
JAMA ONCOLOGY (2019)
Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma
Even H. Rustad et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
The landscape of somatic mutation in normal colorectal epithelial cells
Henry Lee-Six et al.
NATURE (2019)
The mutational footprints of cancer therapies
Oriol Pich et al.
NATURE GENETICS (2019)
Genomic landscape and chronological reconstruction of driver events in multiple myeloma
Francesco Maura et al.
NATURE COMMUNICATIONS (2019)
Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines
F. Maura et al.
LEUKEMIA (2018)
Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma
Yi Jin et al.
BLOOD (2018)
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
Thomas J. Mitchell et al.
CELL (2018)
Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms
Phuc H. Hoang et al.
LEUKEMIA (2018)
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma
Tomas Radivoyevitch et al.
LEUKEMIA RESEARCH (2018)
Genomic patterns of progression in smoldering multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2018)
Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma
Guy Ledergor et al.
NATURE MEDICINE (2018)
Antigen-mediated regulation in monoclonal gammopathies and myeloma
Shiny Nair et al.
JCI INSIGHT (2018)
Genomic complexity of multiple myeloma and its clinical implications
Salomon Manier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
Michel Attal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
L. Rasche et al.
NATURE COMMUNICATIONS (2017)
Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
Niels Weinhold et al.
BLOOD (2016)
Assessment of tumoral plasma cells in apheresis products for autologous stem cell transplantation in multiple myeloma
S. Wuilleme et al.
BONE MARROW TRANSPLANTATION (2016)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Shaji Kumar et al.
LANCET ONCOLOGY (2016)
Tissue-specific mutation accumulation in human adult stem cells during life
Francis Blokzijl et al.
NATURE (2016)
Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma
Shiny Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data
Yu Fan et al.
GENOME BIOLOGY (2016)
The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution
N. Puig et al.
LEUKEMIA (2015)
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2015)
An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers
Kin Chan et al.
NATURE GENETICS (2015)
Clock-like mutational processes in human somatic cells
Ludmil B. Alexandrov et al.
NATURE GENETICS (2015)
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma
Brian A. Walker et al.
NATURE COMMUNICATIONS (2015)
Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution
S. Kasar et al.
NATURE COMMUNICATIONS (2015)
Massive parallel IGHV gene sequencing reveals a germinal center pathway in origins of human multiple myeloma
Graeme Cowan et al.
ONCOTARGET (2015)
PhyloWGS: Reconstructing subclonal composition and evolution from whole-genome sequencing of tumors
Amit G. Deshwar et al.
GENOME BIOLOGY (2015)
Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression
Stephanie Sungalee et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2014)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
Evolution of the cancer genome
Lucy R. Yates et al.
NATURE REVIEWS GENETICS (2012)
The genetic architecture of multiple myeloma
Gareth J. Morgan et al.
NATURE REVIEWS CANCER (2012)
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren et al.
BLOOD (2009)
Expression of the AID protein in normal and neoplastic B cells
L Pasqualucci et al.
BLOOD (2004)
分享论文
